Noga Gershoni‐Emek

499 total citations
13 papers, 358 citations indexed

About

Noga Gershoni‐Emek is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Noga Gershoni‐Emek has authored 13 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Neurology and 4 papers in Genetics. Recurrent topics in Noga Gershoni‐Emek's work include Pharmacological Receptor Mechanisms and Effects (6 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Noga Gershoni‐Emek is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (6 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Noga Gershoni‐Emek collaborates with scholars based in Israel, Canada and United States. Noga Gershoni‐Emek's co-authors include Eran Perlson, Francisca C. Bronfman, Guillermo Moya‐Alvarado, Michal Geva, Michael R. Hayden, Ariel Ionescu, Dianna E. Willis, Topaz Altman, Eran Hornstein and Tal Gradus and has published in prestigious journals such as Nucleic Acids Research, Scientific Reports and Journal of Neurochemistry.

In The Last Decade

Noga Gershoni‐Emek

13 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noga Gershoni‐Emek Israel 10 244 90 89 64 53 13 358
Surabhi Shukla United States 6 215 0.9× 71 0.8× 65 0.7× 87 1.4× 29 0.5× 7 380
Rebecca San Gil Australia 9 233 1.0× 177 2.0× 59 0.7× 88 1.4× 66 1.2× 16 385
Yueming Chang United States 6 285 1.2× 96 1.1× 74 0.8× 49 0.8× 42 0.8× 6 432
Timothy J. Strovas United States 12 235 1.0× 146 1.6× 48 0.5× 142 2.2× 54 1.0× 13 445
Edgar Dawkins Australia 9 174 0.7× 121 1.3× 81 0.9× 214 3.3× 49 0.9× 10 428
Brandon F. Maziuk United States 6 256 1.0× 51 0.6× 55 0.6× 129 2.0× 20 0.4× 6 351
Toni Ahtoniemi Finland 9 191 0.8× 128 1.4× 91 1.0× 194 3.0× 46 0.9× 11 473
Ryotaku Inoue Japan 8 165 0.7× 103 1.1× 79 0.9× 52 0.8× 40 0.8× 10 362
Younghwi Kwon South Korea 9 207 0.8× 214 2.4× 54 0.6× 117 1.8× 61 1.2× 13 432
Yuko Saito Japan 13 319 1.3× 74 0.8× 70 0.8× 131 2.0× 14 0.3× 41 514

Countries citing papers authored by Noga Gershoni‐Emek

Since Specialization
Citations

This map shows the geographic impact of Noga Gershoni‐Emek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noga Gershoni‐Emek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noga Gershoni‐Emek more than expected).

Fields of papers citing papers by Noga Gershoni‐Emek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noga Gershoni‐Emek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noga Gershoni‐Emek. The network helps show where Noga Gershoni‐Emek may publish in the future.

Co-authorship network of co-authors of Noga Gershoni‐Emek

This figure shows the co-authorship network connecting the top 25 collaborators of Noga Gershoni‐Emek. A scholar is included among the top collaborators of Noga Gershoni‐Emek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noga Gershoni‐Emek. Noga Gershoni‐Emek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Geva, Michal, Shaoming Wang, Noga Gershoni‐Emek, et al.. (2022). J11 Pridopidine exerts beneficial effects in preclinical models and in clinical trials via activation of the sigma-1 receptor, in a biphasic manner. A98.1–A98. 1 indexed citations
2.
Lenoir, Sophie, Hélène Vitet, Chiara Scaramuzzino, et al.. (2022). Pridopidine rescues BDNF/TrkB trafficking dynamics and synapse homeostasis in a Huntington disease brain-on-a-chip model. Neurobiology of Disease. 173. 105857–105857. 25 indexed citations
3.
Reilmann, Ralf, Anne Rosser, Sandra K. Kostyk, et al.. (2021). F41 The proof-hd phase 3 study: pridopidine’s outcome on function in huntington disease (PROOF). A36.1–A36. 1 indexed citations
4.
Naia, Luana, Philip T. T. Ly, Sandra I. Mota, et al.. (2021). The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models. Neurotherapeutics. 18(2). 1017–1038. 41 indexed citations
5.
Geva, Michal, Noga Gershoni‐Emek, Luana Naia, et al.. (2021). Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma. Scientific Reports. 11(1). 21975–21975. 9 indexed citations
6.
Shenkman, Marina, Michal Geva, Noga Gershoni‐Emek, Michael R. Hayden, & Gerardo Z. Lederkremer. (2021). Pridopidine reduces mutant huntingtin‐induced endoplasmic reticulum stress by modulation of the Sigma‐1 receptor. Journal of Neurochemistry. 158(2). 467–481. 24 indexed citations
7.
Gershoni‐Emek, Noga, Iliana Barrera, Siddharth Nanguneri, et al.. (2020). Measuring mRNA translation in neuronal processes and somata by tRNA-FRET. Nucleic Acids Research. 48(6). e32–e32. 14 indexed citations
8.
Gershoni‐Emek, Noga, et al.. (2018). Localization of RNAi Machinery to Axonal Branch Points and Growth Cones Is Facilitated by Mitochondria and Is Disrupted in ALS. Frontiers in Molecular Neuroscience. 11. 311–311. 34 indexed citations
9.
Magen, Iddo, Ariel Ionescu, Noga Gershoni‐Emek, et al.. (2017). ALS Along the Axons – Expression of Coding and Noncoding RNA Differs in Axons of ALS models. Scientific Reports. 7(1). 44500–44500. 75 indexed citations
10.
Moya‐Alvarado, Guillermo, Noga Gershoni‐Emek, Eran Perlson, & Francisca C. Bronfman. (2016). Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?. Molecular & Cellular Proteomics. 15(2). 409–425. 87 indexed citations
11.
Gershoni‐Emek, Noga, Michael Chein, Shani Gluska, & Eran Perlson. (2015). Amyotrophic Lateral Sclerosis as a Spatiotemporal Mislocalization Disease: Location, Location, Location. International review of cell and molecular biology. 315. 23–71. 8 indexed citations
12.
Gershoni‐Emek, Noga, Arnon Mazza, Michael Chein, et al.. (2015). Proteomic Analysis of Dynein-Interacting Proteins in Amyotrophic Lateral Sclerosis Synaptosomes Reveals Alterations in the RNA-Binding Protein Staufen1. Molecular & Cellular Proteomics. 15(2). 506–522. 22 indexed citations
13.
Solmesky, Leonardo J., Noga Gershoni‐Emek, Shlomo Bulvik, et al.. (2013). Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1G93A mouse model. Human Molecular Genetics. 22(23). 4720–4725. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Surabhi Shukla Breakdown of academic impact, for papers by Rebecca San Gil Breakdown of academic impact, for papers by Yueming Chang Breakdown of academic impact, for papers by Timothy J. Strovas Breakdown of academic impact, for papers by Edgar Dawkins Breakdown of academic impact, for papers by Brandon F. Maziuk Breakdown of academic impact, for papers by Toni Ahtoniemi Breakdown of academic impact, for papers by Ryotaku Inoue Breakdown of academic impact, for papers by Younghwi Kwon Breakdown of academic impact, for papers by Yuko Saito
Rankless by CCL
2026